Novartis Pharmaceuticals Corporation et al v. MSN Pharmaceuticals Inc. et al
Novartis Pharmaceuticals Corporation |
Astex Therapeutics Ltd. |
MSN Pharmaceuticals Inc. and MSN Laboratories Pvt. Ltd. |
1:2021cv01102 |
July 29, 2021 |
US District Court for the District of Delaware |
Leonard P Stark |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on September 13, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals Inc. filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Pascale, Karen) |
Filing 11 ANSWER to #1 Complaint, , COUNTERCLAIM against All Plaintiffs by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Pascale, Karen) |
Filing 10 STIPULATION TO EXTEND TIME Defendants' Deadline to Answer, Move or Otherwise Respond to the Complaint to Septemebr 13, 2021 - filed by Astex Therapeutics Ltd., Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
Filing 9 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd.: For MSN Laboratories Pvt. Ltd. waiver sent on 8/11/2021, answer due 10/12/2021. (Silver, Daniel) |
SO ORDERED, re #10 STIPULATION TO EXTEND TIME Defendants' Deadline to Answer, Move or Otherwise Respond to the Complaint to Septemebr 13, 2021 filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd. Signed by Judge Leonard P. Stark on 8/12/21. (ntl) |
Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
Filing 8 SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd.. MSN Pharmaceuticals Inc. served on 7/30/2021, answer due 8/20/2021. (Joyce, Alexandra) |
Filing 7 Summons Issued with Magistrate Consent Notice attached as to MSN Laboratories Pvt. Ltd. on 7/29/2021; MSN Pharmaceuticals Inc. on 7/29/2021. (Attachments: #1 Summons Issued)(myr) |
Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka America, Inc., Corporate Parent Otsuka Pharmaceutical Co., Ltd., Corporate Parent Otsuka Holdings Co., Ltd. for Astex Therapeutics Ltd. filed by Astex Therapeutics Ltd.. (myr) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (myr) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,324,225 ;8,415,355 ;8,685,980 ;8,962,630 ;9,416,136. (myr) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than May 18, 2021. Date of Expiration of Patent: See Attached. (myr) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
Filing 1 COMPLAINT filed against MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3668076.) - filed by Novartis Pharmaceuticals Corporation, Astex Therapeutics Ltd. (Attachments: #1 Exhibit A-E, #2 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.